Global
# |
Name |
Return on Capital Employed (ROCE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
1,869.76%
|
Dec. 31, 2023 | USD 3.15 | -5.12% |
|
Canada |
|
2 |
1,410.79%
|
Sept. 30, 2024 | USD 12.31 | -23.96% |
|
United States |
|
3 |
1,328.91%
|
June 30, 2024 | USD 0.89 | -3.59% |
|
United States |
|
4 |
639.13%
|
Dec. 31, 2023 | USD 5.51 | -1.08% |
|
Israel |
|
5 |
555.22%
|
Sept. 30, 2024 | USD 6.52 | -5.10% |
|
United States |
|
6 |
500.73%
|
March 31, 2024 | USD 1.01 | -5.61% |
|
United States |
|
7 |
389.57%
|
Dec. 31, 2023 | USD 9.91 | -0.63% |
|
Italy |
|
8 |
301.99%
|
Sept. 30, 2024 | USD 1.17 | 2.63% |
|
United States |
|
9 |
159.55%
|
Dec. 31, 2023 | USD 0.05 | 1.50% |
|
United Kingdom |
|
10 |
157.54%
|
Dec. 31, 2023 | USD 1.01 | 1.23% |
|
Poland |
|
11 |
96.20%
|
Dec. 31, 2023 | USD 0.36 | 6.46% |
|
China |
|
12 |
61.65%
|
March 31, 2024 | USD 10.94 | 1.86% |
|
United Kingdom |
|
13 |
58.64%
|
Sept. 30, 2024 | USD 6.33 | 4.46% |
|
United States |
|
14 |
51.61%
|
Dec. 31, 2023 | USD 11.90 | 21.74% |
|
South Korea |
|
15 |
44.74%
|
Dec. 31, 2023 | USD 2.32 | 4.82% |
|
China |
|
16 |
43.98%
|
Dec. 31, 2023 | USD 0.41 | 9.86% |
|
China |
|
17 |
39.32%
|
Sept. 30, 2024 | USD 92.62 | -2.15% |
|
United States |
|
18 |
39.28%
|
Dec. 31, 2023 | USD 6.64 | 6.03% |
|
China |
|
19 |
38.86%
|
Sept. 30, 2024 | USD 3.65 | -3.18% |
|
United States |
|
20 |
38.01%
|
July 31, 2024 | USD 6.07 | -3.40% |
|
Japan |
|
21 |
36.66%
|
Sept. 30, 2024 | USD 4.54 | -7.91% |
|
United States |
|
22 |
34.71%
|
March 31, 2024 | USD 1.60 | 0.81% |
|
India |
|
23 |
33.42%
|
Dec. 31, 2023 | USD 2.34 | 1.69% |
|
Poland |
|
24 |
32.88%
|
Sept. 30, 2024 | USD 8.61 | 0.58% |
|
United States |
|
25 |
32.84%
|
Dec. 31, 2023 | USD 9.77 | 0.05% |
|
China |
|
26 |
32.83%
|
Dec. 31, 2023 | USD 23.99 | 3.90% |
|
China |
|
27 |
32.41%
|
Sept. 30, 2024 | USD 3.09 | 0.33% |
|
United States |
|
28 |
31.23%
|
March 31, 2024 | USD 23.77 | 2.82% |
|
India |
|
29 |
30.91%
|
Dec. 31, 2023 | USD 9.59 | -1.93% |
|
Japan |
|
30 |
30.62%
|
March 31, 2024 | USD 81.26 | -0.29% |
|
India |
|
31 |
30.57%
|
June 30, 2024 | USD 70.50 | 0.61% |
|
Denmark |
|
32 |
30.08%
|
Dec. 31, 2023 | USD 2.08 | 1.92% |
|
Canada |
|
33 |
29.31%
|
Dec. 31, 2023 | USD 3.45 | 3.36% |
|
China |
|
34 |
29.31%
|
Sept. 30, 2024 | USD 22.19 | -0.09% |
|
United States |
|
35 |
28.80%
|
Sept. 30, 2024 | USD 36.67 | -1.26% |
|
United States |
|
36 |
28.77%
|
Sept. 30, 2024 | USD 16.32 | -1.03% |
|
United States |
|
37 |
28.44%
|
Dec. 31, 2023 | USD 53.59 | 1.39% |
|
Italy |
|
38 |
28.08%
|
March 31, 2024 | USD 37.58 | 0.68% |
|
India |
|
39 |
27.51%
|
Dec. 31, 2023 | USD 28.50 | 0.53% |
|
Ireland |
|
40 |
27.25%
|
Sept. 30, 2024 | USD 53.83 | -0.57% |
|
United States |
|
41 |
27.11%
|
Dec. 31, 2023 | USD 7.37 | 1.31% |
|
Italy |
|
42 |
26.96%
|
March 31, 2024 | USD 8.37 | 4.44% |
|
India |
|
43 |
26.88%
|
Sept. 30, 2024 | USD 164.41 | -1.15% |
|
United States |
|
44 |
26.86%
|
March 31, 2024 | USD 32.39 | -1.98% |
|
India |
|
45 |
26.78%
|
June 30, 2024 | USD 7.32 | 6.16% |
|
Australia |
|
46 |
26.69%
|
Dec. 31, 2023 | USD 4.89 | 2.67% |
|
China |
|
47 |
26.46%
|
March 31, 2024 | USD 26.89 | 2.81% |
|
India |
|
48 |
26.09%
|
Dec. 31, 2023 | USD 17.87 | 3.09% |
|
Sweden |
|
49 |
25.56%
|
Sept. 30, 2024 | USD 36.42 | -0.08% |
|
United States |
|
50 |
25.47%
|
Dec. 31, 2023 | USD 2.72 | 2.05% |
|
China |
The Biotechnology company with the highest Return on Capital Employed (ROCE) is Achieve Life Sciences, Inc. (NasdaqCM: ACHV) at 1,869.76%.
The Biotechnology company with the lowest Return on Capital Employed (ROCE) is Elutia Inc. (NasdaqCM: ELUT) at -3,223.45%.
The top 10 Biotechnology companies the Global by Return on Capital Employed (ROCE) are Achieve Life Sciences, Inc., Atara Biotherapeutics, Inc., Calidi Biotherapeutics, Inc., RedHill Biopharma Ltd., Avalo Therapeutics, Inc., Allarity Therapeutics, Inc., Newron Pharmaceuticals S.p.A., Plus Therapeutics, Inc., Proteome Sciences plc and Pharmena S.A..
The bottom 10 Biotechnology companies by Return on Capital Employed (ROCE) are Elutia Inc., Ji Yao Holding Group Co., Ltd., NFL Biosciences SA, Daré Bioscience, Inc., 180 Life Sciences Corp., Agenus Inc., Palatin Technologies, Inc., Addex Therapeutics Ltd, Inventiva S.A. and 22nd Century Group, Inc..